We have
state-of-the-art
Approvals Received:
MCAZ Zimbabwe, PPB Kenya, cGMP India
Approvals Received:
cGMP India, NDA Uganda, PPB Kenya, Ethiopian FDA
Approvals Received:
USFDA, Health Canada, NIPN Hungary, cGMP India
Approvals Received:
Health Canada, NIPN Hungary, ANVISA Brazil
Approvals Received:
cGMP India, Malta Medicines Authority, PPB Kenya
Approvals Received:
Health Canada, NIPN Hungary, TGA Australia, MOH Russia,
cGMP India, GCC, ANVISA Brazil, SAHPRA South Africa
Approvals Received:
cGMP India
Approvals Received:
MCAZ Zimbabwe, PPB Kenya, TFDA Tanzania, NDA Uganda,
NMRA Sri Lanka, MOH Russia, cGMP India
Approvals Received:
USFDA, EDQM (Europe), cGMP India
Approvals Received:
USFDA, cGMP India, MCAZ Zimbabwe
Approvals Received:
USFDA, cGMP India
Approvals Received:
State FDA, NDA Uganda, PPB Kenya, Ethiopian FDA
Approvals Received:
cGMP India, NDA Uganda, PPB Kenya, Ethiopian FDA
We manufacture and develop a wide range of orals including solids, liquid orals and dry syrup/suspensions. Our oral solids capabilities include dissolvable & chewable tablets and capsules with a focus on controlled release.
We handle different packaging formats such as vials and pre-filled syringes, and forms such as lyophilized & liquid at our injectable facilities. We are also capable of producing high potency injectables, particularly those related to oncology products through complex processes.
We have two of our facilities dedicated towards manufacturing several different APIs such as intermediates, iron compounds and cytotoxic.
We develop our biopharmaceuticals using the mammalian and microbial expression platforms.
We manufacture and develop a wide range of orals including solids, liquid orals and dry syrup/suspensions. Our oral solids capabilities include dissolvable & chewable tablets and capsules with a focus on controlled release.
We handle different packaging formats such as vials and pre-filled syringes, and forms such as lyophilized & liquid at our injectable facilities. We are also capable of producing high potency injectables, particularly those related to oncology products through complex processes.
We have two of our facilities dedicated towards manufacturing several different APIs such as intermediates, iron compounds and cytotoxic.
We develop our biopharmaceuticals using the mammalian and microbial expression platforms.
Our facilities are capable of producing pharmaceutical products of a wide range of dosage forms, including oral solids, oral liquids, injectables, including complex injectables, such as liposomal and lyophilized injectables, biotherapeutics and complex APIs, including chiral molecules, iron molecules, and cytotoxic products. Our manufacturing and development facilities include formulation through process development, and scale-up and full-scale commercial manufacturing.
Emcure started as a contract development and manufacturing organization (CDMO) business catering to multinational corporations. Our beginning as a CDMO helped us develop the ability to handle complex manufacturing processes at scale, such as lyophilization and complete isolation technology for cytotoxic products. In our manufacturing of biotherapeutics products, we have successfully developed and deployed our microbial and mammalian-based platforms.
All our facilities have also been inspected by various regulatory authorities
Emcure is committed to providing high-quality products to customers. To meet this commitment, we have implemented the latest good manufacturing practices at all manufacturing sites.
In addition to these, we utilize continuous biomanufacturing facilities and perfusion-based technology in India, which require lower capital expenditure to construct, occupy a smaller footprint, require lower operating expenditure and have relatively higher yield.
Our facilities are equipped with advanced technologies that help ensure efficient utilization of resources. We have installed energy efficient equipment, promoted usage of renewable substitutes and have Effluent Treatment Plants (ETP) in most of our facilities that integrate concepts such as Zero Liquid Discharge (ZLD) to reduce the dependency on natural resources.
Our products are manufactured by taking into consideration the potential environmental and social impacts. Our product manufacturing process encompasses business practices that promote inclusion of eco-friendly operations such as efficient raw materials and reducing overall environmental impact in and around the area where we operate.
Our products are manufactured by taking into consideration the potential environmental and social impacts. Our product manufacturing process encompasses business practices that promote inclusion of eco-friendly operations such as efficient raw materials and reducing overall environmental impact in and around the area where we operate.